Contact

All Stories

  1. Prognostic Nutritional Index is a valuable preoperative prognostic biomarker in Mexican patients surgically intervened on gastrointestinal stromal tumors: a retrospective cohort study

    Article • Supportive Care in Cancer, December 2024, Springer Science + Business Media

    Dr. Roberto Herrera-Goepfert

  2. Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the Helicobacter pylori Genome Project

    Article • Gut Microbes, August 2024, Taylor & Francis

    Dr. Roberto Herrera-Goepfert

  3. Unmasked Kaposi and sarcoidosis immune reconstitution inflammatory syndrome in a patient with AIDS

    Article • AIDS, April 2024, Wolters Kluwer Health

    Dr. Roberto Herrera-Goepfert

  4. The Helicobacter pylori Genome Project: insights into H. pylori population structure from analysis of a worldwide collection of complete genomes

    Article • Nature Communications, December 2023, Springer Science + Business Media

    Dr. Roberto Herrera-Goepfert, Dr Ben Pascoe

  5. Multivariate prognostic models for patients with stages I and II colon carcinoma: a strobe-compliant retrospective cohort study

    Article • Revista de investigaci�n Cl�nica, October 2023, Publicidad Permanyer, SLU

    Dr. Roberto Herrera-Goepfert

  6. Circulating miRNAs as Noninvasive Biomarkers for PDAC Diagnosis and Prognosis in Mexico

    Article • International Journal of Molecular Sciences, October 2023, MDPI AG

    Dr. Roberto Herrera-Goepfert

  7. Anaplastic Kaposi Sarcoma of the Right Colon, in a Young Man With Acquired Immunodeficiency Syndrome: A Rare Variant in an Unreported Organ

    Article • International Journal of Surgical Pathology, July 2023, SAGE Publications

    Dr. Roberto Herrera-Goepfert

  8. CD24+CD44+CD54+EpCAM+ gastric cancer stem cells predict tumor progression and metastasis: clinical and experimental evidence

    Article • Stem Cell Research & Therapy, February 2023, Springer Science + Business Media

    Dr. Roberto Herrera-Goepfert

  9. Somatic Mutational Landscape in Mexican Patients: CDH1 Mutations and chr20q13.33 Amplifications Are Associated with Diffuse-Type Gastric Adenocarcinoma

    Article • International Journal of Molecular Sciences, September 2022, MDPI AG

    Dr. Roberto Herrera-Goepfert

  10. H2A.Z overexpression suppresses senescence and chemosensitivity in pancreatic ductal adenocarcinoma

    Article • Oncogene, February 2021, Springer Science + Business Media

    Dr. Roberto Herrera-Goepfert

  11. Portal Dissemination of Fusarium graminearum in a Patient with Acute Lymphoblastic Leukemia and Febrile Neutropenia

    Article • Infectious Disease Reports, January 2021, MDPI AG

    Dr. Roberto Herrera-Goepfert

  12. Obstructive cholangiopathy patient caused by cytomegalovirus and Kaposi sarcoma in a person living with HIV and hepatitis C

    Article • International Journal of STD & AIDS, August 2020, SAGE Publications

    Dr. Roberto Herrera-Goepfert

  13. Nutritional Indexes as Predictors of Survival and Their Genomic Implications in Gastric Cancer Patients

    Article • Nutrition and Cancer, July 2020, Taylor & Francis

    Dr. Roberto Herrera-Goepfert

  14. Association of the prognostic nutritional index and overall survival in patients with colorectal cancer: A STROBE compliant retrospective cohort study

    Article • Cancer Medicine, May 2019, Wiley

    Dr. Roberto Herrera-Goepfert

  15. Prognostic Factors and Differences in Survival of Right and Left Colon Carcinoma: A STROBE Compliant Retrospective Cohort Study

    Article • Archives of Medical Research, February 2019, Elsevier

    Dr. Roberto Herrera-Goepfert

  16. Clinicopathological features related to survival in adenocarcinoma of the Vaterian system in a Mexican population

    Article • Human Pathology, January 2019, Elsevier

    Dr. Roberto Herrera-Goepfert

  17. Carcinoma epidermoide primario del estómago. Reporte de tres casos

    Article • Revista médica de Chile, December 2018, SciELO Comision Nacional de Investigacion Cientifica Y Tecnologica (CONICYT)

    Dr. Roberto Herrera-Goepfert

  18. Carcinoma epidermoide puro-combinado de vesícula biliar

    Article • Revista médica de Chile, December 2018, SciELO Comision Nacional de Investigacion Cientifica Y Tecnologica (CONICYT)

    Dr. Roberto Herrera-Goepfert

  19. Circulating inflammation‐related markers and advanced gastric premalignant lesions

    Article • Journal of Gastroenterology and Hepatology, November 2018, Wiley

    Dr. Roberto Herrera-Goepfert

  20. Quantitative proteomics reveals proteins involved in the progression from non-cancerous lesions to gastric cancer

    Article • Journal of Proteomics, August 2018, Elsevier

    Dr. Roberto Herrera-Goepfert

  21. IV consenso mexicano sobre Helicobacter pylori

    Article • Revista de Gastroenterología de México, July 2018, Elsevier

    Dr. Roberto Herrera-Goepfert

  22. The fourth Mexican consensus on Helicobacter pylori

    Article • Revista de Gastroenterología de México (English Edition), July 2018, Elsevier

    Dr. Roberto Herrera-Goepfert

  23. Su1236 - Circulating Inflammation-Related Markers and Advanced Gastric Premalignant Lesions

    Article • Gastroenterology, May 2018, Elsevier

    Dr. Roberto Herrera-Goepfert

  24. Clinical differences and prognostic factors in right and left colon cancer.

    Article • Journal of Clinical Oncology, February 2018, American Society of Clinical Oncology (ASCO)

    Dr. Roberto Herrera-Goepfert

  25. Postradiation Synovial Sarcoma of the Common Bile Duct

    Article • International Journal of Surgical Pathology, January 2018, SAGE Publications

    Dr. Roberto Herrera-Goepfert

  26. Exenteración pélvica anterior laparoscópica en un paciente con melanoma localmente avanzado

    Article • Cirugía y Cirujanos, December 2017, Publicidad Permanyer, SLU

    Dr. Roberto Herrera-Goepfert

  27. Correction to: Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study

    Article • BMC Cancer, October 2017, Springer Science + Business Media

    Dr. Roberto Herrera-Goepfert

  28. Molecular Characterization of the Human Stomach Microbiota in Gastric Cancer Patients

    Article • Frontiers in Cellular and Infection Microbiology, July 2017, Frontiers

    Dr. Roberto Herrera-Goepfert

  29. Abstract 3257: Molecular characterization of the human stomach microbiota in gastric cancer patients

    Article • Cancer Research, July 2017, American Association for Cancer Research (AACR)

    Dr. Roberto Herrera-Goepfert

  30. P-094Neoadjuvant chemoradiotherapy or chemotherapy preoperative on outcomes of patients with locally advanced or irresecable gastric cancer(LAGC)

    Article • Annals of Oncology, June 2017, Oxford University Press (OUP)

    Dr. Roberto Herrera-Goepfert

  31. PD-022Using clinical data to define a prognostic model for patients with stage I or II colon carcinoma

    Article • Annals of Oncology, June 2017, Oxford University Press (OUP)

    Dr. Roberto Herrera-Goepfert

  32. Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study

    Article • BMC Cancer, May 2017, Springer Science + Business Media

    Dr. Roberto Herrera-Goepfert

  33. Baseline serum albumin and other common clinical markers are prognostic factors in colorectal carcinoma

    Article • Medicine, April 2017, Wolters Kluwer Health

    Dr. Roberto Herrera-Goepfert

  34. Abstract B26: Baseline serum albumin as a prognostic actor in patients with stage I and II colon adenocarcinoma

    Article • Cancer Research, January 2017, American Association for Cancer Research (AACR)

    Dr. Roberto Herrera-Goepfert

  35. Polymorphisms inHLA-DQgenes, together with age, sex, andHelicobacter pyloriinfection, as potential biomarkers for the early diagnosis of gastric cancer

    Article • Helicobacter, June 2016, Wiley

    Dr. Roberto Herrera-Goepfert

  36. Blood serum albumin as prognostic factor in patients with colorectal carcinoma.

    Article • Journal of Clinical Oncology, February 2016, American Society of Clinical Oncology (ASCO)

    Dr. Roberto Herrera-Goepfert

  37. Methylation ofDAPKandTHBS1genes in esophageal gastric-type columnar metaplasia

    Article • World Journal of Gastroenterology, January 2016, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr. Roberto Herrera-Goepfert

  38. Retrospective cohort study of prognostic factors in patients with oral cavity and oropharyngeal squamous cell carcinoma

    Article • Head & Neck, June 2015, Wiley

    Dr. Roberto Herrera-Goepfert

  39. Colonic Cribriform Carcinoma, a Morphologic Pattern Associated With Low Survival

    Article • International Journal of Surgical Pathology, July 2014, SAGE Publications

    Dr. Roberto Herrera-Goepfert

  40. High-risk human papillomavirus (HPV) DNA sequences in metaplastic breast carcinomas of Mexican women

    Article • BMC Cancer, October 2013, Springer Science + Business Media

    Dr. Roberto Herrera-Goepfert

  41. Case-case comparison of smoking and alcohol risk associations with Epstein-Barr virus-positive gastric cancer

    Article • International Journal of Cancer, August 2013, Wiley

    Dr. Roberto Herrera-Goepfert

  42. Abstract 4808: Case-case comparison of smoking and alcohol risk associations with Epstein-Barr virus-positive gastric cancer.

    Article • Cancer Research, April 2013, American Association for Cancer Research (AACR)

    Dr. Roberto Herrera-Goepfert

  43. Improved survival of gastric cancer with tumour Epstein–Barr virus positivity: an international pooled analysis

    Article • Gut, April 2013, BMJ

    Dr Stephen M Hewitt, Dr. Roberto Herrera-Goepfert

  44. Clinicopathological and immunohistochemical analysis of six cases of gastric globoid dysplasia

    Article • Revista Española de Patología, January 2013, Elsevier

    Dr. Roberto Herrera-Goepfert

  45. Cancer Progression Mediated by Horizontal Gene Transfer in an In Vivo Model

    Article • PLoS ONE, December 2012, PLOS

    Dr. Roberto Herrera-Goepfert, Dr Alfredo Hidalgo-Miranda

  46. Mo1587 Epstein-Barr Virus Positivity as a Prognostic Indicator in Gastric Cancer: an International Pooled Analysis

    Article • Gastroenterology, May 2012, Elsevier

    Dr. Roberto Herrera-Goepfert

  47. Disruption of CTCF at the miR-125b1 locus in gynecological cancers

    Article • BMC Cancer, January 2012, Springer Science + Business Media

    Dr. Roberto Herrera-Goepfert

  48. Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis

    Article • British Journal of Cancer, June 2011, Springer Science + Business Media

    Dr. Roberto Herrera-Goepfert

  49. High-risk human papillomavirus in mammary gland carcinomas and non-neoplastic tissues of Mexican women: No evidence supporting a cause and effect relationship

    Article • The Breast, April 2011, Elsevier

    Dr. Roberto Herrera-Goepfert

  50. Methylenetetrahydrofolate Reductase Polymorphism (677 C>T) Predicts Long Time to Progression in Metastatic Colon Cancer Treated with 5-Fluorouracil and Folinic Acid

    Article • Archives of Medical Research, August 2010, Elsevier

    Dr. Roberto Herrera-Goepfert

  51. M1517: Value of Targeted Biopsy With Magnification Endoscopy Plus Narrow Band Imaging Versus Chromoendoscopy in the Diagnosis of Gastric Intestinal Metaplasia

    Article • Gastrointestinal Endoscopy, April 2010, Elsevier

    Dr. Roberto Herrera-Goepfert

  52. Dietary folate and vitamin B12 intake before diagnosis decreases gastric cancer mortality risk among susceptible MTHFR 677TT carriers

    Article • Nutrition, February 2010, Elsevier

    Dr. Roberto Herrera-Goepfert

  53. Dietary intake of polyphenols, nitrate and nitrite and gastric cancer risk in Mexico City

    Article • International Journal of Cancer, September 2009, Wiley

    Dr. Roberto Herrera-Goepfert

  54. Gastric cancer in relation to the intake of nutrients involved in one-carbon metabolism among MTHFR 677 TT carriers

    Article • Zeitschrift für Ernährungswissenschaft, March 2009, Springer Science + Business Media

    Dr. Roberto Herrera-Goepfert

  55. Human papilloma virus and esophageal carcinoma in a Latin-American region

    Article • World Journal of Gastroenterology, January 2009, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr. Roberto Herrera-Goepfert

  56. Selection of best candidates for multiorgan resection among patients with T4 gastric carcinoma

    Article • Journal of Surgical Oncology, October 2008, Wiley

    Dr. Roberto Herrera-Goepfert

  57. Epstein-Barr virus associated gastric carcinoma: Epidemiological and clinicopathological features

    Article • Cancer Science, February 2008, Wiley

    Dr. Roberto Herrera-Goepfert

  58. Experience of surgical morbidity after palliative surgery in patients with gastric carcinoma

    Article • Gastric Cancer, December 2007, Springer Science + Business Media

    Dr. Roberto Herrera-Goepfert

  59. Treatment of the Adenocarcinoma of the Esophagogastric Junction at a Single Institution in Mexico

    Article • Annals of Surgical Oncology, January 2007, Springer Science + Business Media

    Dr. Roberto Herrera-Goepfert

  60. Who are the best candidates for multiorgan resection among patients with T4 gastric carcinoma?

    Article • BMC Cancer, January 2007, Springer Science + Business Media

    Dr. Roberto Herrera-Goepfert

  61. Magnification endoscopy to detect dysplastic aberrant crypt foci in Mexican patients with high risk for colorectal cancer

    Article • BMC Cancer, January 2007, Springer Science + Business Media

    Dr. Roberto Herrera-Goepfert

  62. Prediction of the recurrence probability in patients with parotid gland cancer

    Article • BMC Cancer, January 2007, Springer Science + Business Media

    Dr. Roberto Herrera-Goepfert

  63. Serum Albumin as a Significant Prognostic Factor for Patients with Gastric Carcinoma

    Article • Annals of Surgical Oncology, December 2006, Springer Science + Business Media

    Dr. Roberto Herrera-Goepfert

  64. 54 ORAL Prediction of recurrence in parotid gland carcinoma

    Article • European Journal of Surgical Oncology, November 2006, Elsevier

    Dr. Roberto Herrera-Goepfert

  65. Human papillomavirus in lung carcinomas among three Latin American countries

    Article • Oncology Reports, April 2006, Spandidos Publications

    Dr. Roberto Herrera-Goepfert

  66. Changes of Gene Expression in Gastric Preneoplasia following Helicobacter pylori Eradication Therapy

    Article • Cancer Epidemiology Biomarkers & Prevention, February 2006, American Association for Cancer Research (AACR)

    Dr. Roberto Herrera-Goepfert

  67. Role of the HLA-DQ locus in the development of chronic gastritis and gastric carcinoma in Mexican patients

    Article • World Journal of Gastroenterology, January 2006, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr. Roberto Herrera-Goepfert, Gilberto Vargas-Alarcón

  68. Differential splicing of E6 within human papillomavirus type 18 variants and functional consequences

    Article • Journal of General Virology, September 2005, Society for General Microbiology

    Dr. Roberto Herrera-Goepfert

  69. Antimicrobial Resistance and Characterization ofHelicobacter pyloriStrains Isolated from Mexican Adults with Clinical Outcome

    Article • Journal of Chemotherapy, June 2005, Taylor & Francis

    Dr. Roberto Herrera-Goepfert

  70. Epstein-Barr virus-associated gastric carcinoma: Evidence of age-dependence among a Mexican population

    Article • World Journal of Gastroenterology, January 2005, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr. Roberto Herrera-Goepfert

  71. Histology-specific gender, age and tumor-location distributions of Epstein-Barr virus-associated gastric carcinoma in Japan

    Article • Oncology Reports, September 2004, Spandidos Publications

    Dr. Roberto Herrera-Goepfert

  72. Identification of Patients with High-risk Lymph Node-negative Colorectal Cancer and Potential Benefit from Adjuvant Chemotherapy

    Article • Japanese Journal of Clinical Oncology, June 2004, Oxford University Press (OUP)

    Dr. Roberto Herrera-Goepfert

  73. Helicobacter pylori Eradication and Gastric Preneoplastic Conditions: A Randomized, Double-Blind, Placebo-Controlled Trial

    Article • Cancer Epidemiology Biomarkers & Prevention, January 2004, American Association for Cancer Research (AACR)

    Dr. Roberto Herrera-Goepfert

  74. Verruciform xanthoma of the esophagus

    Article • Human Pathology, August 2003, Elsevier

    Dr. Roberto Herrera-Goepfert

  75. Development of dyspepsia in asymptomatic subjects treated for H. pylori infection: a challenge for screen-and-treat strategies

    Article • Gastroenterology, April 2003, Elsevier

    Dr. Roberto Herrera-Goepfert

  76. Diagnostic yield of gastric biopsy specimens when screening for preneoplastic lesions

    Article • Human Pathology, January 2003, Elsevier

    Dr. Roberto Herrera-Goepfert

  77. Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure

    Article • The American Journal of Gastroenterology, October 2002, Springer Science + Business Media

    Dr. Roberto Herrera-Goepfert

  78. Friction hypermelanosis: Other variants

    Article • Journal of the American Academy of Dermatology, September 2002, Elsevier

    Dr. Roberto Herrera-Goepfert

  79. Pathological disorders of the gastric mucosa surrounding carcinomas and primary lymphomas

    Article • The American Journal of Gastroenterology, June 2001, Springer Science + Business Media

    Dr. Roberto Herrera-Goepfert

  80. Change in worst biopsy diagnosis 1 year after Helicobacter pylori eradication

    Article • Gastroenterology, April 2001, Elsevier

    Dr. Roberto Herrera-Goepfert

  81. Gastric atrophy and extent of intestinal metaplasia in a cohort of Helicobacter pylori–infected patients

    Article • Human Pathology, January 2001, Elsevier

    Dr. Roberto Herrera-Goepfert

  82. Histologic Changes of the Gastric Mucosa Associated With Primary Gastric Lymphoma in Endoscopic Biopsy Specimens

    Article • Archives of Pathology & Laboratory Medicine, November 2000, Archives of Pathology and Laboratory Medicine

    Dr. Roberto Herrera-Goepfert

  83. Gastric sampling for preneoplastic gastric lesions: Are two biopsies from the antrum and one from the fundus enough?

    Article • Gastroenterology, April 2000, Elsevier

    Dr. Roberto Herrera-Goepfert

  84. Interobserver variability in application of the revised sydney classification for gastritis*1, *2

    Article • Human Pathology, December 1999, Elsevier

    Dr. Roberto Herrera-Goepfert

  85. Pathologic Features of the Gastric Mucosa Adjacent to Primary MALT-lymphomas

    Article • Journal of Clinical Gastroenterology, October 1999, Wolters Kluwer Health

    Dr. Roberto Herrera-Goepfert

  86. Single-step PCR amplification and enzyme restriction analysis of the entireHelicobacter pyloricytotoxinvacAgene for genetic variability studies

    Article • FEMS Microbiology Letters, September 1999, Oxford University Press (OUP)

    Dr. Roberto Herrera-Goepfert

  87. Follicular Cheilitis

    Article • American Journal of Dermatopathology, June 1996, Wolters Kluwer Health

    Dr. Roberto Herrera-Goepfert

  88. Hyperpigmentation of the Clavicular Zone: A Variant of Friction Melanosis

    Article • International Journal of Dermatology, March 1989, Wiley

    Dr. Roberto Herrera-Goepfert

  89. Association between takayasu's arteritis and cutaneous polyarteritis nodosa

    Article • The American Journal of Medicine, February 1987, Elsevier

    Dr. Roberto Herrera-Goepfert

  90. Intramitochondrial lamellar bodies in acute myeloblastic leukemia

    Article • Human Pathology, July 1986, Elsevier

    Dr. Roberto Herrera-Goepfert

  91. The precursor lesions of invasive gallbladder carcinoma. Hyperplasia, atypical hyperplasia and carcinoma in situ

    Article • Cancer, March 1980, Wiley

    Dr. Roberto Herrera-Goepfert